Abstract: The present disclosure relates to peptide IL23 receptor antagonists, their pharmaceutical compositions and their medical use, for example in the treatment of inflammatory bowel diseases such as Crohn's disease.
| # | Name | Date |
|---|---|---|
| 1 | 202417098922-TRANSLATIOIN OF PRIOIRTY DOCUMENTS ETC. [13-12-2024(online)].pdf | 2024-12-13 |
| 2 | 202417098922-STATEMENT OF UNDERTAKING (FORM 3) [13-12-2024(online)].pdf | 2024-12-13 |
| 4 | 202417098922-Sequence Listing in PDF [13-12-2024(online)].pdf | 2024-12-13 |
| 5 | 202417098922-REQUEST FOR EXAMINATION (FORM-18) [13-12-2024(online)].pdf | 2024-12-13 |
| 6 | 202417098922-NOTIFICATION OF INT. APPLN. NO. & FILING DATE (PCT-RO-105-PCT Pamphlet) [13-12-2024(online)].pdf | 2024-12-13 |
| 7 | 202417098922-FORM 18 [13-12-2024(online)].pdf | 2024-12-13 |
| 8 | 202417098922-FORM 1 [13-12-2024(online)].pdf | 2024-12-13 |
| 9 | 202417098922-DECLARATION OF INVENTORSHIP (FORM 5) [13-12-2024(online)].pdf | 2024-12-13 |
| 10 | 202417098922-COMPLETE SPECIFICATION [13-12-2024(online)].pdf | 2024-12-13 |
| 11 | 202417098922-Proof of Right [20-02-2025(online)].pdf | 2025-02-20 |
| 12 | 202417098922-FORM-26 [20-02-2025(online)].pdf | 2025-02-20 |
| 13 | 202417098922-FORM 3 [07-04-2025(online)].pdf | 2025-04-07 |